Siemens Healthineers (ETR:SHL) PT Set at €75.00 by Deutsche Bank Aktiengesellschaft

Siemens Healthineers (ETR:SHL) has been given a €75.00 ($85.23) target price by investment analysts at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 25.88% from the stock’s previous close.

Other research analysts also recently issued reports about the company. Jefferies Financial Group set a €62.00 ($70.45) price target on Siemens Healthineers in a research report on Tuesday, November 23rd. Kepler Capital Markets set a €65.00 ($73.86) price target on Siemens Healthineers in a research report on Tuesday. UBS Group set a €59.00 ($67.05) price target on Siemens Healthineers in a research report on Wednesday, November 17th. Nord/LB set a €60.00 ($68.18) price objective on Siemens Healthineers in a research report on Tuesday, January 4th. Finally, Credit Suisse Group set a €71.00 ($80.68) price objective on Siemens Healthineers in a research report on Thursday, November 18th. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Siemens Healthineers currently has an average rating of “Buy” and an average price target of €61.30 ($69.66).

Shares of ETR SHL opened at €59.58 ($67.70) on Thursday. The company has a quick ratio of 0.74, a current ratio of 1.08 and a debt-to-equity ratio of 87.62. The business’s 50 day moving average is €63.75 and its two-hundred day moving average is €59.05. The company has a market cap of $66.89 billion and a P/E ratio of 38.23. Siemens Healthineers has a 12 month low of €41.98 ($47.70) and a 12 month high of €67.66 ($76.89).

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.

Recommended Story: ESG Score

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.